{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "30615092", "DateCompleted": {"Year": "2020", "Month": "03", "Day": "31"}, "DateRevised": {"Year": "2023", "Month": "02", "Day": "16"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.1093/advances/nmy077"], "Journal": {"ISSN": "2156-5376", "JournalIssue": {"Volume": "10", "Issue": "1", "PubDate": {"Year": "2019", "Month": "Jan", "Day": "01"}}, "Title": "Advances in nutrition (Bethesda, Md.)", "ISOAbbreviation": "Adv Nutr"}, "ArticleTitle": "Protective Effects of Epigallocatechin-3-Gallate from Green Tea in Various Kidney Diseases.", "Pagination": {"StartPage": "112", "EndPage": "121", "MedlinePgn": "112-121"}, "Abstract": {"AbstractText": ["Kidney diseases are common health problems worldwide. Various etiologies (e.g., diabetes, hypertension, drug-induced nephrotoxicity, infection, cancers) can affect renal function and ultimately lead to development of chronic kidney disease (CKD) and end-stage renal disease (ESRD). The global rise in number of CKD/ESRD patients during recent years has led to tremendous concern to look for effective strategies to prevent or slow progression of CKD and ESRD. Natural compounds derived from herbs or medicinal plants have gained wide attention for scientific scrutiny to achieve such goals. One of such natural compounds that has been extensively investigated is epigallocatechin-3-gallate (EGCG), a major polyphenol found in the tea plant (Camellia sinensis). A growing body of recent evidence has shown that EGCG may be a promising therapeutic or protective agent in various kidney diseases. This article thus highlights recent progress in medical research on beneficial effects of EGCG against a broad spectrum of kidney diseases, including acute kidney injury, cisplatin-induced nephrotoxicity, kidney stone disease, glomerulonephritis, lupus nephritis, renal cell carcinoma, diabetic nephropathy, CKD, and renal fibrosis. The renoprotective mechanisms are also detailed. Finally, future perspectives of medical research on EGCG and its potential use in clinical practice for treatment and prevention of kidney diseases are discussed."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Proteomics Unit, Office for Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand."}], "LastName": "Kanlaya", "ForeName": "Rattiyaporn", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Proteomics Unit, Office for Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand."}], "LastName": "Thongboonkerd", "ForeName": "Visith", "Initials": "V"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Adv Nutr", "NlmUniqueID": "101540874", "ISSNLinking": "2161-8313"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Protective Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Tea"}, {"RegistryNumber": "8R1V1STN48", "NameOfSubstance": "Catechin"}, {"RegistryNumber": "BQM438CTEL", "NameOfSubstance": "epigallocatechin gallate"}], "MeshHeadingList": [{"QualifierName": ["analogs & derivatives", "pharmacology"], "DescriptorName": "Catechin"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug effects"], "DescriptorName": "Kidney"}, {"QualifierName": ["therapy"], "DescriptorName": "Kidney Diseases"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Protective Agents"}, {"QualifierName": ["chemistry"], "DescriptorName": "Tea"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Couser WG, Remuzzi G, Mendis S, Tonelli M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int. 2011;80:1258\u201370.", "ArticleIdList": ["21993585"]}, {"Citation": "Glassock RJ, Warnock DG, Delanaye P. The global burden of chronic kidney disease: estimates, variability and pitfalls. Nat Rev Nephrol. 2017;13:104\u201314.", "ArticleIdList": ["27941934"]}, {"Citation": "Webster AC, Nagler EV, Morton RL, Masson P. Chronic kidney disease. Lancet. 2017;389:1238\u201352.", "ArticleIdList": ["27887750"]}, {"Citation": "Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, Saran R, Wang AY, Yang CW. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382:260\u201372.", "ArticleIdList": ["23727169"]}, {"Citation": "Chowdhury A, Sarkar J, Chakraborti T, Pramanik PK, Chakraborti S. Protective role of epigallocatechin-3-gallate in health and disease: a perspective. Biomed Pharmacother. 2016;78:50\u20139.", "ArticleIdList": ["26898424"]}, {"Citation": "Yang CS, Chen G, Wu Q. Recent scientific studies of a traditional Chinese medicine, tea, on prevention of chronic diseases. J Tradit Complement Med. 2014;4:17\u201323.", "ArticleIdList": ["PMC4032838", "24872929"]}, {"Citation": "Yong-xing Z, Li S. History and prospect of tea medicine in China. Int J Tea Sci. 2006;5:19\u201327."}, {"Citation": "Kanwar J, Taskeen M, Mohammad I, Huo C, Chan TH, Dou QP. Recent advances on tea polyphenols. Front Biosci (Elite Ed). 2012;4:111\u201331.", "ArticleIdList": ["PMC3303150", "22201858"]}, {"Citation": "Khokhar S, Magnusdottir SG. Total phenol, catechin, and caffeine contents of teas commonly consumed in the United Kingdom. J Agric Food Chem. 2002;50:565\u201370.", "ArticleIdList": ["11804530"]}, {"Citation": "Higdon JV, Frei B. Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit Rev Food Sci Nutr. 2003;43:89\u2013143.", "ArticleIdList": ["12587987"]}, {"Citation": "Mak JC. Potential role of green tea catechins in various disease therapies: progress and promise. Clin Exp Pharmacol Physiol. 2012;39:265\u201373.", "ArticleIdList": ["22229384"]}, {"Citation": "Uttara B, Singh AV, Zamboni P, Mahajan RT. Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol. 2009;7:65\u201374.", "ArticleIdList": ["PMC2724665", "19721819"]}, {"Citation": "Khurana S, Venkataraman K, Hollingsworth A, Piche M, Tai TC. Polyphenols: benefits to the cardiovascular system in health and in aging. Nutrients. 2013;5:3779\u2013827.", "ArticleIdList": ["PMC3820045", "24077237"]}, {"Citation": "Teshima Y, Takahashi N, Nishio S, Saito S, Kondo H, Fukui A, Aoki K, Yufu K, Nakagawa M, Saikawa T. Production of reactive oxygen species in the diabetic heart. Roles of mitochondria and NADPH oxidase. Circ J. 2014;78:300\u20136.", "ArticleIdList": ["24334638"]}, {"Citation": "Bao H, Peng A. The green tea polyphenol (-)-epigallocatechin-3-gallate and its beneficial roles in chronic kidney disease. J Transl Int Med. 2016;4:99\u2013103.", "ArticleIdList": ["PMC5290885", "28191529"]}, {"Citation": "Makris K, Spanou L. Acute kidney injury: diagnostic approaches and controversies. Clin Biochem Rev. 2016;37:153\u201375.", "ArticleIdList": ["PMC5242479", "28167845"]}, {"Citation": "McCaffrey J, Dhakal AK, Milford DV, Webb NJ, Lennon R. Recent developments in the detection and management of acute kidney injury. Arch Dis Child. 2017;102:91\u20136.", "ArticleIdList": ["PMC5256404", "27496911"]}, {"Citation": "Bao GH, Xu J, Hu FL, Wan XC, Deng SX, Barasch J. EGCG inhibit chemical reactivity of iron through forming an Ngal-EGCG-iron complex. Biometals. 2013;26:1041\u201350.", "ArticleIdList": ["PMC4416964", "24158698"]}, {"Citation": "Twal M, Kiefer P, Salameh A, Schnabel J, Ossmann S, von\u00a0Salisch S, Kr\u00e4mer K, Sobiraj A, Kostelka M, Mohr FW et al. . Reno-protective effects of epigallocatechin gallate in a small piglet model of extracorporeal circulation. Pharmacol Res. 2013;67:68\u201378.", "ArticleIdList": ["23103594"]}, {"Citation": "Funamoto M, Masumoto H, Takaori K, Taki T, Setozaki S, Yamazaki K, Minakata K, Ikeda T, Hyon SH, Sakata R. Green tea polyphenol prevents diabetic rats from acute kidney injury after cardiopulmonary bypass. Ann Thorac Surg. 2016;101:1507\u201313.", "ArticleIdList": ["26675556"]}, {"Citation": "Kakuta Y, Okumi M, Isaka Y, Tsutahara K, Abe T, Yazawa K, Ichimaru N, Matsumura K, Hyon SH, Takahara S et al. . Epigallocatechin-3-gallate protects kidneys from ischemia reperfusion injury by HO-1 upregulation and inhibition of macrophage infiltration. Transpl Int. 2011;24:514\u201322.", "ArticleIdList": ["21291499"]}, {"Citation": "Karasawa T, Steyger PS. An integrated view of cisplatin-induced nephrotoxicity and ototoxicity. Toxicol Lett. 2015;237:219\u201327.", "ArticleIdList": ["PMC4516600", "26101797"]}, {"Citation": "El\u00a0Mowafy AM, Al\u00a0Gayyar MM, Salem HA, El\u00a0Mesery ME, Darweish MM. Novel chemotherapeutic and renal protective effects for the green tea (EGCG): role of oxidative stress and inflammatory-cytokine signaling. Phytomedicine. 2010;17:1067\u201375.", "ArticleIdList": ["20851589"]}, {"Citation": "El\u00a0Mowafy AM, Salem HA, Al\u00a0Gayyar MM, El\u00a0Mesery ME, El\u00a0Azab MF. Evaluation of renal protective effects of the green-tea (EGCG) and red grape resveratrol: role of oxidative stress and inflammatory cytokines. Nat Prod Res. 2011;25:850\u20136.", "ArticleIdList": ["21462079"]}, {"Citation": "Sahin K, Tuzcu M, Gencoglu H, Dogukan A, Timurkan M, Sahin N, Aslan A, Kucuk O. Epigallocatechin-3-gallate activates Nrf2/HO-1 signaling pathway in cisplatin-induced nephrotoxicity in rats. Life Sci. 2010;87:240\u20135.", "ArticleIdList": ["20619277"]}, {"Citation": "Pan H, Chen J, Shen K, Wang X, Wang P, Fu G, Meng H, Wang Y, Jin B. Mitochondrial modulation by epigallocatechin-3-gallate ameliorates cisplatin induced renal injury through decreasing oxidative/nitrative stress, inflammation and NF-kB in mice. PLoS One. 2015;10:e0124775.", "ArticleIdList": ["PMC4398485", "25875356"]}, {"Citation": "Zou P, Song J, Jiang B, Pei F, Chen B, Yang X, Liu G, Hu Z. Epigallocatechin-3-gallate protects against cisplatin nephrotoxicity by inhibiting the apoptosis in mouse. Int J Clin Exp Pathol. 2014;7:4607\u201316.", "ArticleIdList": ["PMC4152023", "25197333"]}, {"Citation": "Chen B, Liu G, Zou P, Li X, Hao Q, Jiang B, Yang X, Hu Z. Epigallocatechin-3-gallate protects against cisplatin-induced nephrotoxicity by inhibiting endoplasmic reticulum stress-induced apoptosis. Exp Biol Med (Maywood ). 2015;240:1513\u20139.", "ArticleIdList": ["PMC4935309", "25716017"]}, {"Citation": "Chang EJ, Mun KC. Effect of epigallocatechin gallate on renal function in cyclosporine-induced nephrotoxicity. Transplant Proc. 2004;36:2133\u20134.", "ArticleIdList": ["15518774"]}, {"Citation": "Hisamura F, Kojima-Yuasa A, Huang X, Kennedy DO, Matsui-Yuasa I. Synergistic effect of green tea polyphenols on their protection against FK506-induced cytotoxicity in renal cells. Am J Chin Med. 2008;36:615\u201324.", "ArticleIdList": ["18543393"]}, {"Citation": "Thongboonkerd V. Proteomics and kidney stone disease. Contrib Nephrol. 2008;160:142\u201358.", "ArticleIdList": ["18401167"]}, {"Citation": "Vinaiphat A, Thongboonkerd V. Prospects for proteomics in kidney stone disease. Expert Rev Proteomics. 2017;14:185\u20137.", "ArticleIdList": ["28092479"]}, {"Citation": "Hall PM. Nephrolithiasis: treatment, causes, and prevention. Cleve Clin J Med. 2009;76:583\u201391.", "ArticleIdList": ["19797458"]}, {"Citation": "Frochot V, Daudon M. Clinical value of crystalluria and quantitative morphoconstitutional analysis of urinary calculi. Int J Surg. 2016;36:624\u201332.", "ArticleIdList": ["27847293"]}, {"Citation": "Vupputuri S, Soucie JM, McClellan W, Sandler DP. History of kidney stones as a possible risk factor for chronic kidney disease. Ann Epidemiol. 2004;14:222\u20138.", "ArticleIdList": ["15036227"]}, {"Citation": "Gillen DL, Worcester EM, Coe FL. Decreased renal function among adults with a history of nephrolithiasis: a study of NHANES III. Kidney Int. 2005;67:685\u201390.", "ArticleIdList": ["15673317"]}, {"Citation": "Rule AD, Bergstralh EJ, Melton LJ III, Li X, Weaver AL, Lieske JC. Kidney stones and the risk for chronic kidney disease. Clin J Am Soc Nephrol. 2009;4:804\u201311.", "ArticleIdList": ["PMC2666438", "19339425"]}, {"Citation": "Hippisley-Cox J, Coupland C. Predicting the risk of chronic kidney disease in men and women in England and Wales: prospective derivation and external validation of the QKidney Scores. BMC Fam Pract. 2010;11:49.", "ArticleIdList": ["PMC2905345", "20565929"]}, {"Citation": "Charrier MJ, Savage GP, Vanhanen L. Oxalate content and calcium binding capacity of tea and herbal teas. Asia Pac J Clin Nutr. 2002;11:298\u2013301.", "ArticleIdList": ["12495262"]}, {"Citation": "Itoh Y, Yasui T, Okada A, Tozawa K, Hayashi Y, Kohri K. Preventive effects of green tea on renal stone formation and the role of oxidative stress in nephrolithiasis. J Urol. 2005;173:271\u20135.", "ArticleIdList": ["15592095"]}, {"Citation": "Jeong BC, Kim BS, Kim JI, Kim HH. Effects of green tea on urinary stone formation: an in vivo and in vitro study. J Endourol. 2006;20:356\u201361.", "ArticleIdList": ["16724910"]}, {"Citation": "Hirose M, Tozawa K, Okada A, Hamamoto S, Shimizu H, Kubota Y, Itoh Y, Yasui T, Kohri K. Glyoxylate induces renal tubular cell injury and microstructural changes in experimental mouse. Urol Res. 2008;36:139\u201347.", "ArticleIdList": ["18542940"]}, {"Citation": "Kanlaya R, Singhto N, Thongboonkerd V. EGCG decreases binding of calcium oxalate monohydrate crystals onto renal tubular cells via decreased surface expression of alpha-enolase. J Biol Inorg Chem. 2016;21:339\u201346.", "ArticleIdList": ["26898643"]}, {"Citation": "Thongboonkerd V, Semangoen T, Chutipongtanate S. Factors determining types and morphologies of calcium oxalate crystals: molar concentrations, buffering, pH, stirring and temperature. Clin Chim Acta. 2006;367:120\u201331.", "ArticleIdList": ["16458875"]}, {"Citation": "Thongboonkerd V, Semangoen T, Sinchaikul S, Chen ST. Proteomic analysis of calcium oxalate monohydrate crystal-induced cytotoxicity in distal renal tubular cells. J Proteome Res. 2008;7:4689\u2013700.", "ArticleIdList": ["18850734"]}, {"Citation": "Vinaiphat A, Aluksanasuwan S, Manissorn J, Sutthimethakorn S, Thongboonkerd V. Response of renal tubular cells to differential types and doses of calcium oxalate crystals: integrative proteome network analysis and functional investigations. Proteomics. 2017;17(15\u201316):1700192.", "ArticleIdList": ["28627733"]}, {"Citation": "Peerapen P, Chaiyarit S, Thongboonkerd V. Protein network analysis and functional studies of calcium oxalate crystal-induced cytotoxicity in renal tubular epithelial cells. Proteomics. 2018;18(8):e1800008.", "ArticleIdList": ["29464862"]}, {"Citation": "Fong-ngern K, Peerapen P, Sinchaikul S, Chen ST, Thongboonkerd V. Large-scale identification of calcium oxalate monohydrate crystal-binding proteins on apical membrane of distal renal tubular epithelial cells. J Proteome Res. 2011;10:4463\u201377.", "ArticleIdList": ["21859077"]}, {"Citation": "Kanlaya R, Fong-ngern K, Thongboonkerd V. Cellular adaptive response of distal renal tubular cells to high-oxalate environment highlights surface alpha-enolase as the enhancer of calcium oxalate monohydrate crystal adhesion. J Proteomics. 2013;80C:55\u201365.", "ArticleIdList": ["23352899"]}, {"Citation": "Fong-ngern K, Vinaiphat A, Thongboonkerd V. Microvillar injury in renal tubular epithelial cells induced by calcium oxalate crystal and the protective role of epigallocatechin-3-gallate. FASEB J. 2017;31:120\u201331.", "ArticleIdList": ["27825102"]}, {"Citation": "Sanders JS, Rutgers A, Stegeman CA, Kallenberg CG. Pulmonary: renal syndrome with a focus on anti-GBM disease. Semin Respir Crit Care Med. 2011;32:328\u201334.", "ArticleIdList": ["21674418"]}, {"Citation": "Ortega LM, Schultz DR, Lenz O, Pardo V, Contreras GN. Review: lupus nephritis: pathologic features, epidemiology and a guide to therapeutic decisions. Lupus. 2010;19:557\u201374.", "ArticleIdList": ["20089610"]}, {"Citation": "Peng A, Ye T, Rakheja D, Tu Y, Wang T, Du Y, Zhou JK, Vaziri ND, Hu Z, Mohan C et al. . The green tea polyphenol (-)-epigallocatechin-3-gallate ameliorates experimental immune-mediated glomerulonephritis. Kidney Int. 2011;80:601\u201311.", "ArticleIdList": ["21544063"]}, {"Citation": "Low G, Huang G, Fu W, Moloo Z, Girgis S. Review of renal cell carcinoma and its common subtypes in radiology. World J Radiol. 2016;8:484\u2013500.", "ArticleIdList": ["PMC4882405", "27247714"]}, {"Citation": "Ye T, Zhen J, Du Y, Zhou JK, Peng A, Vaziri ND, Mohan C, Xu Y, Zhou XJ. Green tea polyphenol (-)-epigallocatechin-3-gallate restores Nrf2 activity and ameliorates crescentic glomerulonephritis. PLoS One. 2015;10:e0119543.", "ArticleIdList": ["PMC4364748", "25785827"]}, {"Citation": "Tsai PY, Ka SM, Chang JM, Chen HC, Shui HA, Li CY, Hua KF, Chang WL, Huang JJ, Yang SS et al. . Epigallocatechin-3-gallate prevents lupus nephritis development in mice via enhancing the Nrf2 antioxidant pathway and inhibiting NLRP3 inflammasome activation. Free Radic Biol Med. 2011;51:744\u201354.", "ArticleIdList": ["21641991"]}, {"Citation": "Peairs A, Dai R, Gan L, Shimp S, Rylander MN, Li L, Reilly CM. Epigallocatechin-3-gallate (EGCG) attenuates inflammation in MRL/lpr mouse mesangial cells. Cell Mol Immunol. 2010;7:123\u201332.", "ArticleIdList": ["PMC4001894", "20140007"]}, {"Citation": "Yu SS, Quinn DI, Dorff TB. Clinical use of cabozantinib in the treatment of advanced kidney cancer: efficacy, safety, and patient selection. Onco Targets Ther. 2016;9:5825\u201337.", "ArticleIdList": ["PMC5045229", "27713636"]}, {"Citation": "Kawashima A, Young SW, Takahashi N, King BF, Atwell TD. Inherited renal carcinomas. Abdom Radiol (NY). 2016;41:1066\u201378.", "ArticleIdList": ["27108134"]}, {"Citation": "Young JR, Margolis D, Sauk S, Pantuck AJ, Sayre J, Raman SS. Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT. Radiology. 2013;267:444\u201353.", "ArticleIdList": ["23382290"]}, {"Citation": "Yoshioka N, Hiasa Y, Cho M, Kitahori Y, Hirao K, Konishi N, Kuwashima S. Effect of polyphenon-60 on the development of renal cell tumors in rats treated with N-ethyl-N hydroxyethylnitrosamine. Cancer Lett. 1999;136:79\u201382.", "ArticleIdList": ["10211943"]}, {"Citation": "Yamasaki H. Role of disrupted gap junctional intercellular communication in detection and characterization of carcinogens. Mutat Res. 1996;365:91\u2013105.", "ArticleIdList": ["8898991"]}, {"Citation": "Takahashi H, Nomata K, Mori K, Matsuo M, Miyaguchi T, Noguchi M, Kanetake H. The preventive effect of green tea on the gap junction intercellular communication in renal epithelial cells treated with a renal carcinogen. Anticancer Res. 2004;24:3757\u201362.", "ArticleIdList": ["15736408"]}, {"Citation": "Sato A, Sekine M, Kobayashi M, Virgona N, Ota M, Yano T. Induction of the connexin 32 gene by epigallocatechin-3-gallate potentiates vinblastine-induced cytotoxicity in human renal carcinoma cells. Chemotherapy. 2013;59:192\u20139.", "ArticleIdList": ["24335094"]}, {"Citation": "Hirai A, Yano T, Nishikawa K, Suzuki K, Asano R, Satoh H, Hagiwara K, Yamasaki H. Down-regulation of connexin 32 gene expression through DNA methylation in a human renal cell carcinoma cell. Am J Nephrol. 2003;23:172\u20137.", "ArticleIdList": ["12690227"]}, {"Citation": "Yano T, Ito F, Kobayashi K, Yonezawa Y, Suzuki K, Asano R, Hagiwara K, Nakazawa H, Toma H, Yamasaki H. Hypermethylation of the CpG island of connexin 32, a candidate tumor suppressor gene in renal cell carcinomas from hemodialysis patients. Cancer Lett. 2004;208:137\u201342.", "ArticleIdList": ["15142671"]}, {"Citation": "Takano Y, Iwata H, Yano Y, Miyazawa M, Virgona N, Sato H, Ueno K, Yano T. Up-regulation of connexin 32 gene by 5-aza-2'-deoxycytidine enhances vinblastine-induced cytotoxicity in human renal carcinoma cells via the activation of JNK signalling. Biochem Pharmacol. 2010;80:463\u201370.", "ArticleIdList": ["20510207"]}, {"Citation": "Gu B, Ding Q, Xia G, Fang Z. EGCG inhibits growth and induces apoptosis in renal cell carcinoma through TFPI-2 overexpression. Oncol Rep. 2009;21:635\u201340.", "ArticleIdList": ["19212621"]}, {"Citation": "Roomi MW, Ivanov V, Kalinovsky T, Niedzwiecki A, Rath M. Anticancer effect of lysine, proline, arginine, ascorbic acid and green tea extract on human renal adenocarcinoma line 786-0. Oncol Rep. 2006;16:943\u20137.", "ArticleIdList": ["17016575"]}, {"Citation": "Chen SJ, Yao XD, Peng BO, Xu YF, Wang GC, Huang J, Liu M, Zheng JH. Epigallocatechin-3-gallate inhibits migration and invasion of human renal carcinoma cells by downregulating matrix metalloproteinase-2 and matrix metalloproteinase-9. Exp Ther Med. 2016;11:1243\u20138.", "ArticleIdList": ["PMC4812156", "27073430"]}, {"Citation": "Ojima A, Ishibashi Y, Matsui T, Maeda S, Nishino Y, Takeuchi M, Fukami K, Yamagishi S. Glucagon-like peptide-1 receptor agonist inhibits asymmetric dimethylarginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product-induced protein arginine methyltranferase-1 expression. Am J Pathol. 2013;182:132\u201341.", "ArticleIdList": ["23159951"]}, {"Citation": "Juan YS, Chuang SM, Long CY, Lin RJ, Liu KM, Wu WJ, Huang CH. Protein kinase C inhibitor prevents renal apoptotic and fibrotic changes in response to partial ureteric obstruction. BJU Int. 2012;110:283\u201392.", "ArticleIdList": ["22145940"]}, {"Citation": "Gnudi L, Coward RJM, Long DA. Diabetic nephropathy: perspective on novel molecular mechanisms. Trends Endocrinol Metab. 2016;27:820\u201330.", "ArticleIdList": ["27470431"]}, {"Citation": "Yamabe N, Yokozawa T, Oya T, Kim M. Therapeutic potential of (-)-epigallocatechin 3-O-gallate on renal damage in diabetic nephropathy model rats. J Pharmacol Exp Ther. 2006;319:228\u201336.", "ArticleIdList": ["16835369"]}, {"Citation": "Yoon SP, Maeng YH, Hong R, Lee BR, Kim CG, Kim HL, Chung JH, Shin BC. Protective effects of epigallocatechin gallate (EGCG) on streptozotocin-induced diabetic nephropathy in mice. Acta Histochem. 2014;116:1210\u20135.", "ArticleIdList": ["25154791"]}, {"Citation": "Igarashi K, Honma K, Yoshinari O, Nanjo F, Hara Y. Effects of dietary catechins on glucose tolerance, blood pressure and oxidative status in Goto-Kakizaki rats. J Nutr Sci Vitaminol (Tokyo). 2007;53:496\u2013500.", "ArticleIdList": ["18202537"]}, {"Citation": "Liang YJ, Jian JH, Liu YC, Juang SJ, Shyu KG, Lai LP, Wang BW, Leu JG. Advanced glycation end products-induced apoptosis attenuated by PPARdelta activation and epigallocatechin gallate through NF-kappaB pathway in human embryonic kidney cells and human mesangial cells. Diabetes Metab Res Rev. 2010;26:406\u201316.", "ArticleIdList": ["20583309"]}, {"Citation": "Leu JG, Lin CY, Jian JH, Shih CY, Liang YJ. Epigallocatechin-3-gallate combined with alpha lipoic acid attenuates high glucose-induced receptor for advanced glycation end products (RAGE) expression in human embryonic kidney cells. An Acad Bras Cienc. 2013;85:745\u201352.", "ArticleIdList": ["23780308"]}, {"Citation": "Yang XH, Pan Y, Zhan XL, Zhang BL, Guo LL, Jin HM. Epigallocatechin-3-gallate attenuates renal damage by suppressing oxidative stress in diabetic db/db mice. Oxid Med Cell Longev. 2016;2016:2968462.", "ArticleIdList": ["PMC5028863", "27698952"]}, {"Citation": "Wang Y, Wang B, Du F, Su X, Sun G, Zhou G, Bian X, Liu N. Epigallocatechin-3-gallate attenuates unilateral ureteral obstruction-induced renal interstitial fibrosis in mice. J Histochem Cytochem. 2015;63:270\u20139.", "ArticleIdList": ["PMC4374055", "25549657"]}, {"Citation": "Wang Y, Wang B, Du F, Su X, Sun G, Zhou G, Bian X, Liu N. Epigallocatechin-3-gallate attenuates oxidative stress and inflammation in obstructive nephropathy via NF-\u03baB and Nrf2/HO-1 signalling pathway regulation. Basic Clin Pharmacol Toxicol. 2015;117:164\u201372.", "ArticleIdList": ["25625183"]}, {"Citation": "Wang Y, Liu N, Su X, Zhou G, Sun G, Du F, Bian X, Wang B. Epigallocatechin-3-gallate attenuates transforming growth factor-\u03b21 induced epithelial-mesenchymal transition via Nrf2 regulation in renal tubular epithelial cells. Biomed Pharmacother. 2015;70:260\u20137.", "ArticleIdList": ["25776510"]}, {"Citation": "Zhou P, Yu JF, Zhao CG, Sui FX, Teng X, Wu YB. Therapeutic potential of EGCG on acute renal damage in a rat model of obstructive nephropathy. Mol Med Rep. 2013;7:1096\u2013102.", "ArticleIdList": ["23358654"]}, {"Citation": "Chen J, Du L, Li J, Song H. Epigallocatechin-3-gallate attenuates cadmium-induced chronic renal injury and fibrosis. Food Chem Toxicol. 2016;96:70\u20138.", "ArticleIdList": ["27474435"]}, {"Citation": "Kanlaya R, Khamchun S, Kapincharanon C, Thongboonkerd V. Protective effect of epigallocatechin-3-gallate (EGCG) via Nrf2 pathway against oxalate-induced epithelial mesenchymal transition (EMT) of renal tubular cells. Sci Rep. 2016;6:30233.", "ArticleIdList": ["PMC4958994", "27452398"]}, {"Citation": "Tachibana H. Green tea polyphenol sensing. Proc Jpn Acad Ser B Phys Biol Sci. 2011;87:66\u201380.", "ArticleIdList": ["PMC3066547", "21422740"]}, {"Citation": "Clifford MN, van\u00a0der\u00a0Hooft JJ, Crozier A. Human studies on the absorption, distribution, metabolism, and excretion of tea polyphenols. Am J Clin Nutr. 2013;98:1619S\u201330S.", "ArticleIdList": ["24172307"]}, {"Citation": "Mizooku Y, Yoshikawa M, Tsuneyoshi T, Arakawa R. Analysis of oxidized epigallocatechin gallate by liquid chromatography/mass spectrometry. Rapid Commun Mass Spectrom. 2003;17:1915\u20138.", "ArticleIdList": ["12876693"]}, {"Citation": "Song S, Huang YW, Tian Y, Wang XJ, Sheng J. Mechanism of action of (-)-epigallocatechin-3-gallate: auto-oxidation-dependent activation of extracellular signal-regulated kinase 1/2 in Jurkat cells. Chin J Nat Med. 2014;12:654\u201362.", "ArticleIdList": ["25263976"]}, {"Citation": "Neilson AP, Song BJ, Sapper TN, Bomser JA, Ferruzzi MG. Tea catechin auto-oxidation dimers are accumulated and retained by Caco-2 human intestinal cells. Nutr Res. 2010;30:327\u201340.", "ArticleIdList": ["PMC2929646", "20579525"]}, {"Citation": "Ishii T, Ichikawa T, Minoda K, Kusaka K, Ito S, Suzuki Y, Akagawa M, Mochizuki K, Goda T, Nakayama T. Human serum albumin as an antioxidant in the oxidation of (-)-epigallocatechin gallate: participation of reversible covalent binding for interaction and stabilization. Biosci Biotechnol Biochem. 2011;75:100\u20136.", "ArticleIdList": ["21228463"]}, {"Citation": "Hou Z, Sang S, You H, Lee MJ, Hong J, Chin KV, Yang CS. Mechanism of action of (\u2212)-epigallocatechin-3-gallate: auto-oxidation-dependent inactivation of epidermal growth factor receptor and direct effects on growth inhibition in human esophageal cancer KYSE 150 cells. Cancer Res. 2005;65:8049\u201356.", "ArticleIdList": ["16140980"]}, {"Citation": "Sang S, Lee MJ, Hou Z, Ho CT, Yang CS. Stability of tea polyphenol (-)-epigallocatechin-3-gallate and formation of dimers and epimers under common experimental conditions. J Agric Food Chem. 2005;53:9478\u201384.", "ArticleIdList": ["16302765"]}, {"Citation": "Krupkova O, Ferguson SJ, Wuertz-Kozak K. Stability of (-)-epigallocatechin gallate and its activity in liquid formulations and delivery systems. J Nutr Biochem. 2016;37:1\u201312.", "ArticleIdList": ["27770867"]}, {"Citation": "Krook MA, Hagerman AE. Stability of polyphenols epigallocatechin gallate and pentagalloyl glucose in a simulated digestive system. Food Res Int. 2012;49:112\u20136.", "ArticleIdList": ["PMC3460640", "23028206"]}, {"Citation": "Fangueiro JF, Parra A, Silva AM, Egea MA, Souto EB, Garcia ML, Calpena AC. Validation of a high performance liquid chromatography method for the stabilization of epigallocatechin gallate. Int J Pharm. 2014;475:181\u201390.", "ArticleIdList": ["25175728"]}, {"Citation": "Proniuk S, Liederer BM, Blanchard J. Preformulation study of epigallocatechin gallate, a promising antioxidant for topical skin cancer prevention. J Pharm Sci. 2002;91:111\u20136.", "ArticleIdList": ["11782902"]}, {"Citation": "Hatano T, Tsugawa M, Kusuda M, Taniguchi S, Yoshida T, Shiota S, Tsuchiya T. Enhancement of antibacterial effects of epigallocatechin gallate, using ascorbic acid. Phytochemistry. 2008;69:3111\u20136.", "ArticleIdList": ["17889045"]}, {"Citation": "Wang S, Su R, Nie S, Sun M, Zhang J, Wu D, Moustaid-Moussa N. Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals. J Nutr Biochem. 2014;25:363\u201376.", "ArticleIdList": ["PMC3959237", "24406273"]}, {"Citation": "Dube A, Nicolazzo JA, Larson I. Chitosan nanoparticles enhance the plasma exposure of (\u2212)-epigallocatechin gallate in mice through an enhancement in intestinal stability. Eur J Pharm Sci. 2011;44:422\u20136.", "ArticleIdList": ["21925598"]}, {"Citation": "Hong Z, Xu Y, Yin JF, Jin J, Jiang Y, Du Q. Improving the effectiveness of (\u2212)-epigallocatechin gallate (EGCG) against rabbit atherosclerosis by EGCG-loaded nanoparticles prepared from chitosan and polyaspartic acid. J Agric Food Chem. 2014;62:12603\u20139.", "ArticleIdList": ["25483592"]}, {"Citation": "Siddiqui IA, Bharali DJ, Nihal M, Adhami VM, Khan N, Chamcheu JC, Khan MI, Shabana S, Mousa SA, Mukhtar H. Excellent anti-proliferative and pro-apoptotic effects of (-)-epigallocatechin-3-gallate encapsulated in chitosan nanoparticles on human melanoma cell growth both in vitro and in vivo. Nanomedicine. 2014;10:1619\u201326.", "ArticleIdList": ["24965756"]}, {"Citation": "Ding J, Kong X, Yao J, Wang J, Cheng X, Tang B, He Z. Core-shell mesoporous silica nanoparticles improve HeLa cell growth and proliferation inhibition by (-)-epigallocatechin-3-gallate by prolonging the half-life. J Mater Chem. 2012;22:19926\u201331."}, {"Citation": "Luo X, Guan R, Chen X, Tao M, Ma J, Zhao J. Optimization on condition of epigallocatechin-3-gallate (EGCG) nanoliposomes by response surface methodology and cellular uptake studies in Caco-2 cells. Nanoscale Res Lett. 2014;9:291.", "ArticleIdList": ["PMC4059483", "24959109"]}, {"Citation": "Radhakrishnan R, Kulhari H, Pooja D, Gudem S, Bhargava S, Shukla R, Sistla R. Encapsulation of biophenolic phytochemical EGCG within lipid nanoparticles enhances its stability and cytotoxicity against cancer. Chem Phys Lipids. 2016;198:51\u201360.", "ArticleIdList": ["27234272"]}, {"Citation": "Shukla R, Chanda N, Zambre A, Upendran A, Katti K, Kulkarni RR, Nune SK, Casteel SW, Smith CJ, Vimal J et al. . Laminin receptor specific therapeutic gold nanoparticles (198AuNP-EGCg) show efficacy in treating prostate cancer. Proc Natl Acad Sci U S A. 2012;109:12426\u201331.", "ArticleIdList": ["PMC3411993", "22802668"]}, {"Citation": "Chung JE, Tan S, Gao SJ, Yongvongsoontorn N, Kim SH, Lee JH, Choi HS, Yano H, Zhuo L, Kurisawa M et al. . Self-assembled micellar nanocomplexes comprising green tea catechin derivatives and protein drugs for cancer therapy. Nat Nanotechnol. 2014;9:907\u201312.", "ArticleIdList": ["PMC4221637", "25282044"]}, {"Citation": "Peter B, Bosze S, Horvath R. Biophysical characteristics of proteins and living cells exposed to the green tea polyphenol epigallocatechin-3-gallate (EGCg): review of recent advances from molecular mechanisms to nanomedicine and clinical trials. Eur Biophys J. 2017;46:1\u201324.", "ArticleIdList": ["27313063"]}, {"Citation": "Han DW, Matsumura K, Kim B, Hyon SH. Time-dependent intracellular trafficking of FITC-conjugated epigallocatechin-3-O-gallate in L-929 cells. Bioorg Med Chem. 2008;16:9652\u20139.", "ArticleIdList": ["18951028"]}, {"Citation": "Palermo CM, Westlake CA, Gasiewicz TA. Epigallocatechin gallate inhibits aryl hydrocarbon receptor gene transcription through an indirect mechanism involving binding to a 90 kDa heat shock protein. Biochemistry. 2005;44:5041\u201352.", "ArticleIdList": ["15794642"]}, {"Citation": "Kuzuhara T, Sei Y, Yamaguchi K, Suganuma M, Fujiki H. DNA and RNA as new binding targets of green tea catechins. J Biol Chem. 2006;281:17446\u201356.", "ArticleIdList": ["16641087"]}, {"Citation": "Huang Y, Sumida M, Kumazoe M, Sugihara K, Suemasu Y, Yamada S, Yamashita S, Miyakawa J, Takahashi T, Tanaka H et al. . Oligomer formation of a tea polyphenol, EGCG, on its sensing molecule 67 kDa laminin receptor. Chem Commun (Camb). 2017;53:1941\u20134.", "ArticleIdList": ["28079202"]}, {"Citation": "Patra SK, Rizzi F, Silva A, Rugina DO, Bettuzzi S. Molecular targets of (-)-epigallocatechin-3-gallate (EGCG): specificity and interaction with membrane lipid rafts. J Physiol Pharmacol. 2008;59(Suppl 9):217\u201335.", "ArticleIdList": ["19261982"]}, {"Citation": "Lorenz M. Cellular targets for the beneficial actions of tea polyphenols. Am J Clin Nutr. 2013;98:1642S\u201350S.", "ArticleIdList": ["24172299"]}]}], "History": [{"Year": "2018", "Month": "5", "Day": "17"}, {"Year": "2018", "Month": "9", "Day": "12"}, {"Year": "2019", "Month": "1", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "4", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "1", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "1", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["30615092", "PMC6370267", "10.1093/advances/nmy077", "S2161-8313(22)01292-3"]}}]}